Loading...
Cart
0
New

Biotechnology Media, Sera and Reagents Market by Type (Media, Sera and Reagent), Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, and Others), and End User (Biotechnology & Pharmaceutical Companies, Academic Institute, Research Laboratory): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

LI_195176
Pages: 240
Feb 2019 | 1641 Views
 
Author(s) : Kavita Joshi & Onkar Sumant
Tables: 123
Charts: 39
 

Biotechnology Media, Sera And Reagents Market Overview:

The global biotechnology media, sera and reagents market was valued at $18,794 million in 2017 and is estimated to reach at $32,974 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.

Biotechnology can be defined as a technological application that uses biological systems, living organisms, and their components to develop innovative products and other technological systems for human welfare. Media, sera and reagents finds their application on several biotechnological research purposes including cancer research, development of biopharmaceuticals, regenerative medicine and other research purposes. In addition, culture media is any solid or liquid preparation made precisely for the growth, storage, maintenance, and transport of microorganisms and different types of cells. The array of various media available in research allows the culturing of cell types and microorganisms. Whereas, sera are used as an additional media supplement used for cell culture, owing to the presence of high content of embryonic growth promoting factors. Further, reagent can be described as a substance or mixture that is used in chemical analysis or other reactions. There are variety of reagents used in biotechnological research such as DNA/RNA isolation reagents, buffers, washing solutions, stains, chemicals and many others.

Get more information on this report: Request Sample Pages

Rise in research and development regarding the development of biopharmaceuticals have fueled the growth of the global biotechnology media, sera and reagents industry. In addition, the constant expansion of biopharmaceutical research is anticipated to create surge the demand on the production and supply chain for cell culture media and reagents market. Moreover, increase in investments and funding for research interventions in both developed and developing countries drives the market growth. For instance, GE Healthcare, in 2018, has increased its production capacity of powdered cell culture media by tenfold in Austria. This was done owing to the increased demand of powdered cell culture media by the customers in Europe. However, ethical & scientific concerns associated with the potential of misuse of biotechnology research practices and dearth of skilled personnel restrict the biotechnology media, sera and reagents market growth.

However, untapped potential of the emerging markets and increase in preference for specialty media are anticipated to provide lucrative opportunities to the key players involved in the biotechnology media, sera and reagents market.

Get more information on this report: Request Sample Pages

Type segment review

Based on biotechnology media, sera and reagents market analysis by type, the market is categorized into media, sera and reagents. The reagents segment was the highest contributor to the market in 2017 and is anticipated to maintain its dominance throughout the forecast period. This was attributed to the fact that reagents find their wide applications in various research areas in biotechnology. For instance, various reagents are used for different research purposes.

Get more information on this report: Request Sample Pages

Application segment review

Based on application, the biotech media, sera and reagent market is classified into cancer research, biopharmaceuticals, regenerative medicine & tissue engineering and others. The biopharmaceuticals segment is anticipated to grow at the highest rate in the forecast period. This is attributed to the significant increase in biotech R&D activities regarding the development of biopharmaceuticals for the treatment of various diseases across the globe.

Get more information on this report: Request Sample Pages

Region segment review

Based on region, the biotechnology media, sera and reagents market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2017, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to the increased funding by the government agencies and rise in focus to develop biopharmaceuticals in this region. However, as per biotechnology media, sera and reagents market forecast, Asia-Pacific is projected to register the highest growth rate from 2018 to 2025.

The report provides a comprehensive analysis of the leading companies operating in the global market such as GE Healthcare, Bio-Rad laboratories Inc., Merck KGaA (Sigma Aldrich), Sartorius AG, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, Merck & Co., Inc., Thermofisher Scientific, Corning Incorporated, Becton, Dickinson and Company. The other players in the value chain (not included in the report) include Takara Bio, Inc., Cyagen Biosciences, PeproTech, Inc., Avantor Performance Materials, LLC (VWR International, LLC), Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH.

Key Benefits for Biotechnology Media, Sera And Reagents Market:

  • The study provides an in-depth analysis of the global biotechnology media, sera and reagents market share with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market size of global biotechnology sera, media and reagent is provided.
  • A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
  • An extensive analysis of the key segments of the industry helps understand the global biotechnology media, sera and reagents market trends.
  • Key players and their strategies are provided to understand the competitive outlook of the industry.

Biotechnology Media, Sera And Reagents Key Market Segments:

By Type

  • Media
    • Lysogeny Broth
    • Classical Media
    • Serum Free Media
    • Chemically Defined Media
    • Specialty Media
    • Stem Cell Media
    • Others
  • Sera
    • Fetal Bovine Sera
    • New Born Calf Sera
    • Others
  • Reagents
    • Antibiotics
    • DNA/RNS Isolation Reagents
    • PCR Reagents
    • Buffers
    • Others

By Application

  • Cancer Research
  • Biopharmaceuticals
  • Regenerative Medicine & Tissue Engineering
  • Others

By End User

  • Biotechnology & Pharmaceutical Companies
  • Academic Institute
  • Research Laboratory

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Saudi Arabia
    • South Africa
    • Brazil
    • Rest of LAMEA
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments

1.3.1.    List of key players profiled in the report

1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings of the study

2.1.1.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top investment pockets
3.2.2.    Top winning strategies

3.3.    Market share analysis, 2017
3.4.    Market dynamics

3.4.1.    Drivers

3.4.1.1.    Rise in R&D Investment
3.4.1.2.    Increase in advancements associated with cell culture media
3.4.1.3.    High demand for media, sera and reagents

3.4.2.    Restraints

3.4.2.1.    Dearth of skilled professionals
3.4.2.2.    Ethical & scientific concerns associated with culture media

3.4.3.    Opportunity

3.4.3.1.    Untapped potential of the emerging economies

CHAPTER 4:    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Media

4.2.1.    Key market trends and opportunity
4.2.2.    Market size and forecast, by region
4.2.3.    Market analysis, by country
4.2.4.    Lysogeny broth

4.2.4.1.    Market size and forecast

4.2.5.    Chemically defined media

4.2.5.1.    Market size and forecast

4.2.6.    Classical media

4.2.6.1.    Market size and forecast

4.2.7.    Serum-free Media

4.2.7.1.    Market size and forecast

4.2.8.    Specialty media

4.2.8.1.    Market size and forecast

4.2.9.    Stem cell media

4.2.9.1.    Market size and forecast

4.2.10.    Other media

4.2.10.1.    Market size and forecast

4.3.    Sera

4.3.1.    Key market trends and opportunity

4.3.1.1.    Market size and forecast

4.3.3.    Market analysis, by country
4.3.4.    Fetal Bovine Sera Market

4.3.4.1.    Market size and forecast

4.3.5.    New Born Calf Sera

4.3.5.1.    Market size and forecast

4.3.6.    others

4.3.6.1.    Market size and forecast

4.4.    Reagent

4.4.1.    Key market trends and opportunity

4.4.1.1.    Market size and forecast

4.4.2.    Market analysis, by country
4.4.3.    Antibiotics

4.4.3.1.    Market size and forecast

4.4.4.    DNA/RNA Isolation Reagents

4.4.4.1.    Market size and forecast

4.4.5.    PCR Reagents

4.4.5.1.    Market size and forecast

4.4.6.    Buffers

4.4.6.1.    Market size and forecast

4.4.7.    Other reagents

4.4.7.1.    Market size and forecast

CHAPTER 5:    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET BY APPLICATION

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Cancer research

5.2.1.    Market size and forecast, by region
5.2.2.    Market analysis, by country

5.3.    Biopharmaceuticals

5.3.1.    Market size and forecast, by region
5.3.2.    Market analysis, by country

5.4.    Regenerative medicine & tissue engineering

5.4.1.    Market size and forecast, by region
5.4.2.    Market analysis, by country

5.5.    Other Applications

5.5.1.    Market size and forecast, by region
5.5.2.    Market analysis, by country

CHAPTER 6:    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Biotechnology & pharmaceutical industry

6.2.1.    Market size and forecast, by region
6.2.2.    Market analysis, by country

6.3.    Academic institute

6.3.1.    Market size and forecast, by region
6.3.2.    Market analysis, by country

6.4.    Research laboratory

6.4.1.    Market size and forecast, by region
6.4.2.    Market analysis, by country

CHAPTER 7:    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY REGION

7.1.    Overview

7.1.1.    Market size and forecast

7.2.    North America

7.2.1.    Key market trends and opportunities
7.2.2.    North America biotechnology media, sera and reagents market size and forecast, by country

7.2.2.1.    U.S. market size and forecast, by type
7.2.2.2.    U.S. market size and forecast, by application
7.2.2.3.    U.S. biotechnology media, sera and reagents market, by end user
7.2.2.4.    Canada market size and forecast, by type
7.2.2.5.    Canada biotechnology media, sera and reagents market, by application
7.2.2.6.    Canada biotechnology media, sera and reagents market, by end user
7.2.2.7.    Mexico biotechnology media, sera and reagents market, by type
7.2.2.8.    Mexico biotechnology media, sera and reagents market, by application
7.2.2.9.    Mexico biotechnology media, sera and reagents market, by end user

7.2.3.    North America biotechnology media, sera and reagents market size and forecast, by type
7.2.4.    North America biotechnology media, sera and reagents market size and forecast, by application
7.2.5.    North America biotechnology media, sera and reagents market size and forecast, by end user

7.3.    Europe

7.3.1.    Key market trends
7.3.2.    Europe biotechnology media, sera and reagents market size and forecast, by country

7.3.2.1.    Germany market size and forecast, by type
7.3.2.2.    Germany biotechnology media, sera and reagents market, by application
7.3.2.3.    Germany biotechnology media, sera and reagents market, by end user
7.3.2.4.    France market size and forecast, by type
7.3.2.5.    France biotechnology media, sera and reagents market, by application
7.3.2.6.    France biotechnology media, sera and reagents market, by end user
7.3.2.7.    UK market size and forecast, by type
7.3.2.8.    UK biotechnology media, sera and reagents market, by application
7.3.2.9.    UK biotechnology media, sera and reagents market, by end user
7.3.2.10.    Italy market size and forecast, by type
7.3.2.11.    Italy biotechnology media, sera and reagents market, by application
7.3.2.12.    Italy biotechnology media, sera and reagents market, by end user
7.3.2.13.    Spain biotechnology media, sera and reagents market, by type
7.3.2.14.    Spain biotechnology media, sera and reagents market, by application
7.3.2.15.    Spain biotechnology media, sera and reagents market, by end user
7.3.2.16.    Rest of Europe biotechnology media, sera and reagents market, by type
7.3.2.17.    Rest of Europe biotechnology media, sera and reagents market, by application
7.3.2.18.    Rest of Europe biotechnology media, sera and reagents market, by end user

7.3.3.    Europe biotechnology media, sera and reagents market size and forecast, by type
7.3.4.    Europe biotechnology media, sera and reagents market size and forecast, by application
7.3.5.    Europe biotechnology media, sera and reagents market size and forecast, by end user

7.4.    Asia-Pacific

7.4.1.    Key market trends
7.4.2.    Asia-Pacific biotechnology media, sera and reagents market size and forecast, by country

7.4.2.1.    Japan biotechnology media, sera and reagents market, by type
7.4.2.2.    Japan biotechnology media, sera and reagents market, by application
7.4.2.3.    Japan biotechnology media, sera and reagents market, by end user
7.4.2.4.    China biotechnology media, sera and reagents market, by type
7.4.2.5.    China biotechnology media, sera and reagents market, by application
7.4.2.6.    China biotechnology media, sera and reagents market, by end user
7.4.2.7.    India biotechnology media, sera and reagents market, by type
7.4.2.8.    India biotechnology media, sera and reagents market, by application
7.4.2.9.    India biotechnology media, sera and reagents market, by end user
7.4.2.10.    Australia biotechnology media, sera and reagents market, by type
7.4.2.11.    Australia biotechnology media, sera and reagents market, by application
7.4.2.12.    Australia biotechnology media, sera and reagents market, by end user
7.4.2.13.    South Korea biotechnology media, sera and reagents market, by type
7.4.2.14.    South Korea biotechnology media, sera and reagents market, by application
7.4.2.15.    South Korea biotechnology media, sera and reagents market, by end user
7.4.2.16.    Taiwan biotechnology media, sera and reagents market, by type
7.4.2.17.    Taiwan biotechnology media, sera and reagents market, by application
7.4.2.18.    Taiwan biotechnology media, sera and reagents market, by end user
7.4.2.19.    Rest of Asia-Pacific biotechnology media, sera and reagents market, by type
7.4.2.20.    Rest of Asia-Pacific biotechnology media, sera and reagents market, by application
7.4.2.21.    Rest of Asia-Pacific biotechnology media, sera and reagents market, by end user

7.4.3.    Asia-Pacific biotechnology media, sera and reagents market size and forecast, by type
7.4.4.    Asia-Pacific biotechnology media, sera and reagents market size and forecast, by application
7.4.5.    Asia-Pacific biotechnology media, sera and reagents market size and forecast, by end user

7.5.    LAMEA

7.5.1.    Key market trends
7.5.2.    LAMEA biotechnology media, sera and reagents market size and forecast, by country

7.5.2.1.    Brazil biotechnology media, sera and reagents market, by type
7.5.2.2.    Brazil biotechnology media, sera and reagents market, by application
7.5.2.3.    Brazil biotechnology media, sera and reagents market, by end user
7.5.2.4.    Saudi Arabia biotechnology media, sera and reagents market, by type
7.5.2.5.    Saudi Arabia biotechnology media, sera and reagents market, by application
7.5.2.6.    Saudi Arabia biotechnology media, sera and reagents market, by end user
7.5.2.7.    South Africa biotechnology media, sera and reagents market, by type
7.5.2.8.    South Africa biotechnology media, sera and reagents market, by application
7.5.2.9.    South Africa biotechnology media, sera and reagents market, by end user
7.5.2.10.    Rest of LAMEA biotechnology media, sera and reagents market, by type
7.5.2.11.    Rest of LAMEA biotechnology media, sera and reagents market, by application
7.5.2.12.    Rest of LAMEA biotechnology media, sera and reagents market, by end user

7.5.3.    LAMEA biotechnology media, sera and reagents market size and forecast, by type
7.5.4.    LAMEA biotechnology media, sera and reagents market size and forecast, by application
7.5.5.    LAMEA biotechnology media, sera and reagents market size and forecast, by end user

CHAPTER 8:    COMPANY PROFILES

8.1.    Production capacity and facility of key companies
8.2.    Becton, Dickinson and Company

8.2.1.    Company overview
8.2.2.    Company snapshot
8.2.3.    Operating business segments
8.2.4.    Business performance
8.2.5.    Key strategic moves and developments

8.3.    Bio-Rad Laboratories Inc.

8.3.1.    Company overview
8.3.2.    Company snapshot
8.3.3.    Operating business segments
8.3.4.    Business performance

8.4.    Corning Incorporated

8.4.1.    Company overview
8.4.2.    Company snapshot
8.4.3.    Operating business segments
8.4.4.    Business performance

8.5.    GE Healthcare

8.5.1.    Company overview
8.5.2.    Company snapshot
8.5.3.    Operating business segments
8.5.4.    Business performance
8.5.5.    Key strategic moves and developments

8.6.    HiMedia Laboratories Pvt., Ltd

8.6.1.    Company overview
8.6.2.    Company snapshot
8.6.3.    Operating business segments
8.6.4.    Key strategic moves and developments

8.7.    Lonza Group Ltd

8.7.1.    Company overview
8.7.2.    Company snapshot
8.7.3.    Operating business segments
8.7.4.    Business performance
8.7.5.    Key strategic moves and developments

8.8.    Merck & Co., Inc.

8.8.1.    Company overview
8.8.2.    Company snapshot
8.8.3.    Operating business segments
8.8.4.    Product portfolio
8.8.5.    Key strategic moves and developments

8.9.    Sartorius AG

8.9.1.    Company overview
8.9.2.    Company snapshot
8.9.3.    Operating business segments
8.9.4.    Business performance
8.9.5.    Key strategic moves and developments

8.10.    Thermo Fisher Scientific Inc.

8.10.1.    Company overview
8.10.2.    Company snapshot
8.10.3.    Operating business segments
8.10.4.    Business performance
8.10.5.    Key strategic moves and developments

LIST OF TABLES

TABLE 01.    GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKETBY TYPE, 2017–2025 ($MILLION)
TABLE 02.    BIOTECHNOLOGY MEDIA MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 01.    LYSOGENY BROTH CULTURE MEDIA MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 02.    CHEMICALLY DEFINED CULTURE MEDIA MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 03.    CLASSICAL CULTURE MEDIA MARKET, BY REGION, 2017 –2025 ($MILLION)
TABLE 04.    SERUM-FREE CULTURE MEDIA MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 05.    SPECIALTY CULTURE MEDIA MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 06.    STEM CELL CULTURE MEDIA MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 07.    OTHER CULTURE MEDIA MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 08.    BIOTECHNOLOGY SERA MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 09.    BIOTECHNOLOGY FETAL BOVINE SERA MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 10.    BIOTECHNOLOGY NEW BORN CALF SERA MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 11.    BIOTECHNOLOGY FETAL BOVINE SERA MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 12.    BIOTECHNOLOGY REAGENTS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 13.    BIOTECHNOLOGY REAGENTS MARKET, FOR ANTIBIOTICS BY REGION, 2017–2025 ($MILLION)
TABLE 14.    BIOTECHNOLOGY REAGENTS MARKET, FOR DNA/RNA ISOLATION REAGENTS BY REGION, 2017–2025 ($MILLION)
TABLE 15.    BIOTECHNOLOGY REAGENTS MARKET, FOR PCR REAGENTS BY REGION, 2017–2025 ($MILLION)
TABLE 16.    BIOTECHNOLOGY REAGENTS MARKET, FOR BUFFERS BY REGION, 2017–2025 ($MILLION)
TABLE 17.    BIOTECHNOLOGY REAGENTS MARKET, FOR OTHER REAGENTS BY REGION, 2017–2025 ($MILLION)
TABLE 18.    GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 19.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR CANCER RESEARCH, BY REGION, 2017–2025 ($MILLION)
TABLE 20.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOPHARMACEUTICALS, BY REGION, 2017–2025 ($MILLION)
TABLE 21.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING, BY REGION, 2017–2025 ($MILLION)
TABLE 22.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2023 ($MILLION)
TABLE 23.    GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY END USER, 2017–2025($MILLION)
TABLE 24.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY, BY REGION, 2017–2025 ($MILLION)
TABLE 25.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR ACADEMIC INSTITUTE, BY REGION, 2017–2025($MILLION)
TABLE 26.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR RESEARCH LABORATORY, BY REGION, 2017–2025($MILLION)
TABLE 27.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY REGION, 2017–2025($MILLION)
TABLE 28.    NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 2017–2025($MILLION)
TABLE 29.    U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 30.    U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 31.    U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 32.    CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 33.    CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 34.    CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 35.    MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 36.    MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 37.    MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 38.    NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 39.    NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 40.    EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 41.    EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 2017–2025($MILLION)
TABLE 42.    GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 43.    GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 44.    GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 45.    FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 46.    FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 47.    FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 48.    UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 49.    UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 50.    UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 51.    ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 52.    ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 53.    ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 54.    SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 55.    SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 56.    SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 57.    REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 58.    REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 59.    REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 60.    EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 61.    EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 62.    EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 63.    ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 2017–2025($MILLION)
TABLE 64.    JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 65.    JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 66.    JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 67.    CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 68.    CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 69.    CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 70.    INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 71.    INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 72.    INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 73.    AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 74.    AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 75.    AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 76.    SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 77.    SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 78.    SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 79.    TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 80.    TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 81.    TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 82.    REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 83.    REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 84.    REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 85.    ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 86.    ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 87.    ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 88.    LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 2017–2025($MILLION)
TABLE 89.    BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 90.    BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 91.    BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 92.    SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 93.    SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 94.    SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 95.    SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 96.    SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 97.    SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 98.    REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 99.    REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 100.    REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 101.    LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 2017–2025($MILLION)
TABLE 102.    LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 2017–2025($MILLION)
TABLE 103.    LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 2017–2025($MILLION)
TABLE 104.    PRODUCTION CAPACITY AND FACILITY OF KEY PLAYERS: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, 2018
TABLE 105.    BD: COMPANY SNAPSHOT
TABLE 106.    BD: OPERATING SEGMENTS
TABLE 107.    BIO-RAD: COMPANY SNAPSHOT
TABLE 108.    BIO-RAD: OPERATING SEGMENTS
TABLE 109.    CORNING: COMPANY SNAPSHOT
TABLE 110.    CORNING: OPERATING SEGMENTS
TABLE 111.    GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 112.    GE HEALTHCARE: OPERATING SEGMENTS
TABLE 113.    HIMEDIA: COMPANY SNAPSHOT
TABLE 114.    HIMEDIA: OPERATING SEGMENTS
TABLE 115.    LONZA: COMPANY SNAPSHOT
TABLE 116.    LONZA: OPERATING SEGMENTS
TABLE 117.    MERCK: COMPANY SNAPSHOT
TABLE 118.    MERCK: OPERATING SEGMENTS
TABLE 119.    MERK: PRODUCT PORTFOLIO
TABLE 120.    SARTORIUS: COMPANY SNAPSHOT
TABLE 121.    SARTORIUS: OPERATING SEGMENTS
TABLE 122.    THERMO FISHER: COMPANY SNAPSHOT
TABLE 123.    THERMO FISHER: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 01.    BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET SEGMENTATION
FIGURE 02.    TOP INVESTMENT POCKETS
FIGURE 03.    TOP WINNING STRATEGIES, BY YEAR, 2015–2018*
FIGURE 04.    TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015–2018*
FIGURE 05.    TOP WINNING STRATEGIES, BY COMPANY, 2015–2018*
FIGURE 06.    MARKET SHARE ANALYSIS, 2017
FIGURE 07.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA MARKET, 2017 AND 2025 ($MILLION)
FIGURE 08.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY SERA MARKET, 2017 AND 2025 ($MILLION)
FIGURE 09.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY REAGENTS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 10.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR CANCER RESEARCH, 2017 AND 2025 ($MILLION)
FIGURE 11.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOPHARMACEUTICALS, 2017 AND 2025 ($MILLION)
FIGURE 12.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING, 2017 AND 2025 ($MILLION)
FIGURE 13.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR OTHER APPLICATIONS, 2017 AND 2025 ($MILLION)
FIGURE 14.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY, 2017 AND 2025 ($MILLION)
FIGURE 15.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR ACADEMIC INSTITUTE, 2017 AND 2025 ($MILLION)
FIGURE 16.    COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR RESEARCH LABORATORY, 2017 AND 2025 ($MILLION)
FIGURE 17.    BD: NET SALES, 2015–2017 ($MILLION)
FIGURE 18.    BD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 19.    BD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 20.    BIO-RAD: NET SALES, 2015–2017 ($MILLION)
FIGURE 21.    BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 22.    BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 23.    CORNING: NET SALES, 2015–2017 ($MILLION)
FIGURE 24.    CORNING: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 25.    CORNING: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 26.    GE HEALTHCARE: NET SALES, 2015–2017 ($MILLION)
FIGURE 27.    GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 28.    GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 29.    LONZA: NET SALES, 2015–2017 ($MILLION)
FIGURE 30.    LONZA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 31.    MERCK: NET SALES, 2015–2016 ($MILLION)
FIGURE 32.    MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33.    MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34.    SARTORIUS: NET SALES, 2015–2017 ($MILLION)
FIGURE 35.    SARTORIUS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36.    SARTORIUS: REVENUE SHARE BY GEOGRAPHY, 2017(%)
FIGURE 37.    THERMO FISHER: NET SALES, 2015–2017 ($MILLION)
FIGURE 38.    THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39.    THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

 
 

Biotechnology is a comprehensive discipline in which biological processes, microorganisms, cells or cellular components are exploited to develop new innovative technologies for human welfare. New technologies and products developed by biotechnologists find their applications in the field of research, agriculture and industry. Moreover, biotechnology has witnessed an exponential growth in recent years and is anticipated to create tremendous opportunities in the near future as well. The growth of the market is driven by factors such as increase in funding & investment for R&D activities and innovation in the life science industry. In addition, increased focus toward the development of biopharmaceuticals and cancer treatment drugs has led to the increase in demand for culture media, sera, and reagents. Furthermore, significant rise in the use of sera for cell culture and low supply of the same is anticipated to increase the cost in near future. However, scientific and ethical concerns associated with biotechnology and dearth of skilled professionals hamper the growth of the market.

North America accounted for a major market share in the biotechnology media, sera and reagent market owing to the fact that the government agencies in this region have increased their focus toward biotechnology research. In addition, advanced healthcare infrastructure and penetration of leading biotech companies further boost the market growth in this region. Moreover, Asia-Pacific region is anticipated to grow at the highest rate during the forecast period. This is attributed to the rise in small scale biotech companies and increased healthcare infrastructure in this region.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Download Sample

Request Customization

 

Download Sample

OR

Purchase Full Report of
Biotechnology Media, Sera and Reagents Market

  • Online Only
  • $3456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3840
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5370
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Buy Full Version
"Biotechnology Media, Sera and Reagents Market"
Purchase Enquiry